{"nct_id":"NCT04879329","title":"A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2022-05-03","start_date_type":"ACTUAL","primary_completion_date":"2026-12-11","primary_completion_date_type":"ESTIMATED","completion_date":"2029-04-14","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["PFE"]}